Goldman Sachs’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $50K | Buy |
|
|||||
|
2021
Q4 | $34K | Sell |
|
|||||
|
2021
Q3 | $152K | Sell |
|
|||||
|
2021
Q2 | $425K | Sell |
|
|||||
|
2021
Q1 | $759K | Buy |
|
|||||
|
2020
Q4 | $639K | Sell |
|
|||||
|
2020
Q3 | $525K | Sell |
|
|||||
|
2020
Q2 | $823K | Buy |
|
|||||
|
2020
Q1 | $517K | Sell |
|
|||||
|
2019
Q4 | $774K | Buy |
|
|||||
|
2019
Q3 | $360K | Sell |
|
|||||
|
2019
Q2 | $695K | Buy |
|
|||||
|
2019
Q1 | $908K | Buy |
|
|||||
|
2018
Q4 | $539K | Buy |
|
|||||
|
2018
Q3 | $427K | Sell |
|
|||||
|
2018
Q2 | $554K | Sell |
|
|||||
|
2018
Q1 | $1.19M | Buy |
|
|||||
|
2017
Q4 | $1.4M | Buy |
|
|||||
|
2017
Q3 | $2.18M | Buy |
|
|||||
|
2017
Q2 | $1.92M | Sell |
|
|||||
|
2017
Q1 | $1.55M | Buy |
|
|||||
|
2016
Q4 | $52K | Buy |
|
|||||
|
2016
Q3 | $36K | Sell |
|
|||||
|
2016
Q2 | $91K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $168K | Buy |
|